Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02122861
Title A Phase 1 Safety Study of Intradermal ID-LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Immune Design


lung non-small cell carcinoma


fallopian tube carcinoma

ovarian cancer

breast cancer



Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
San Francisco Oncology Associates San Francisco California 94115 United States Details
Yale University New Haven Connecticut 06520 United States Details
Dana Farber Harvard Cancer Center Boston Massachusetts 02215 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Greenville Health System Greenville South Carolina 29605 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Seattle Cancer Care Alliance Seattle Washington 98102 United States Details
*Shaded cells indicate that there was no data available from for the field